The international biopharmaceutical corporation, Ipsen, successfully concluded its purchase of ImCheck Therapeutics on December 15, 2025, in Paris, France. This... Read more
Category: Uncategorized
Pharmaceutical Company Declares Highest-Ever Cash Dividend Payout
Hai Phong Pharmaceutical Joint Stock Company (stock code: DPH) has announced its plan to pay a cash dividend for the... Read more
Vietnamese Healthcare Facility Deploys New Generation Diagnostic Imaging Equipment
Phenikaa University Hospital (PhenikaaMec) has officially commissioned the Philips Ingenia Elition X 3 Tesla Magnetic Resonance Imaging (MRI) system. This... Read more
Sanofi Signs Potential $1 Billion Deal for Alzheimer’s Antibody Asset
Sanofi has entered into a licensing agreement with Adel, a clinical-stage biotech based in Seoul, South Korea, for the development... Read more
Alphyn Biologics Secures $25 Million in Series B Funding
Alphyn Biologics, a US-based biotechnology company, has successfully completed a Series B funding round, raising $25 million. The round was... Read more
SOBI Agrees to Acquire Arthrosi Therapeutics
Swedish Orphan Biovitrum (SOBI) has reached an agreement to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly... Read more
Pharmaceutical Manufacturer Gaelic Labs Acquires Athlone Laboratories
Gaelic Laboratories, a pharmaceutical manufacturer specializing in Beta-Lactam (penicillin) products, has acquired Athlone Laboratories, a developer and manufacturer of oral... Read more
Strategic Partnership Expanded Between Dren Bio and Sanofi for Next-Generation B-Cell Therapy
Dren Bio, a privately held, clinical-stage biotechnology company, announced an expanded strategic collaboration with Sanofi for the discovery and development... Read more
PARP Combination Therapy Expands Treatment Indication in Prostate Cancer
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for a targeted combination therapy for patients with... Read more








